To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...

Join our two-day training to deepen your understanding of vaccine history, types, and GMP-compliant production. Learn about raw materials, quality assurance, and risk management strategies. Enhance ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Discover the bioanalytical strategies crucial for unlocking the potential of LNP-mRNA vaccines. Explore the impact of these strategies on the development and efficacy of mRNA vaccines.

Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.